Journal
JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 287, Issue 22, Pages 18055-18066Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M111.333989
Keywords
-
Categories
Funding
- Canadian Institutes of Health Research
- Canadian Arthritis Network
Ask authors/readers for more resources
In addition to its classical CD40 receptor, CD154 also binds to alpha IIb beta 3, alpha 5 beta 1, and alpha M beta 2 integrins. Binding of CD154 to these receptors seems to play a key role in the pathogenic processes of chronic inflammation. This investigation was aimed at analyzing the functional interaction of CD154 with CD40, alpha IIb beta 3, and alpha 5 beta 1 receptors. We found that the binding affinity of CD154 for alpha IIb beta 3 is similar to 4-fold higher than for alpha 5 beta 1. We also describe the generation of sCD154 mutants that lost their ability to bind CD40 or alpha IIb beta 3 and show that CD154 residues involved in its binding to CD40 or alpha IIb beta 3 are distinct from those implicated in its interaction to alpha 5 beta 1, suggesting that sCD154 may bind simultaneously to different receptors. Indeed, sCD154 can bind simultaneously to CD40 and alpha 5 beta 1 and biologically activate human monocytic U937 cells expressing both receptors. The simultaneous engagement of CD40 and alpha 5 beta 1 activates the mitogen-activated protein kinases, p38, and extracellular signal-related kinases 1/2 and synergizes in the release of inflammatory mediators MMP-2 and -9, suggesting a cross-talk between these receptors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available